Methods for the preparation of [3a-3H]ergosta-7,22-dien-3,B-ol (5,6-dihydroergosterol), [5,6-3H2] To differentiate between a hydroxylation-dehydration mechanism and a dehydrogenation mechanism, the metabolism of [3a-3H]ergosta-7,22-diene-3,B,5a-diol was studied. It was shown that this diol is converted into ergosterol only under aerobic conditions.
Continuing studies on the enzymic aspect of biosynthesis of yeast sterols (Akhtar, Parvez & Hunt, 1966a) we now report on the mechanism of introduction of the 5,6-double bond in the elaboration of ring B of ergosterol (VIIb). It is now well established that the final stages in cholesterol (VIII) biosynthesis involve the migration of 8,9-double bond (partial structure I) to the 7,8-position to give A7-cholestenol (Ila) , an oxidative reaction then results in the introduction of a new double bond between C-5 and C-6 to give a 5,7-diene system (VIIa) and finally an NADPH-linked reaction (Akhtar, Wilton & Munday, 1966b) completes the conversion of the diene system (VIIa) into cholesterol. We have previously studied the mechanism of the introduction of the 5,6-double bond in the hepatic biosynthesis of cholesterol (VIII). Two basic mechanisms were considered for the origin of this double bond: a hydroxylationdehydration mechanism and a dehydrogenation mechanism (Akhtar & Marsh, 1967) . The hydroxylation-dehydration mechanism outlined in Scheme 1 requires the first step of the sequence to occur under aerobic conditions and the second step under anaerobic conditions.
The failure of the three hydroxylated compounds (cholest-7-ene-3fl,6oc-diol, cholest-7-ene-3fl,6fl-diol and cholest-7-ene-3fl,5a-diol) to serve as precursors of cholesterol under anaerobic conditions and the inability of 1X7-cholestenol (IIa) to furnish any of the hydroxylated intermediates under the conditions of cholesterol biosynthesis led us to discard the hydroxylation-dehydration mechanism as an explanation of the introduction of the 5,6-double bond in the biosynthesis. We therefore favoured an oxygen-dependent dehydrogenation mechanism for the conversion of structure (IIa) into structure (VIIa) in the cholesterol series (Dewhurst & Akhtar, 1967) .
Recently, however, Topham & Gaylor (1967) have studied the parallel reaction in the biosynthesis of ergosterol and have provided evidence in support of a hydroxylation-dehydration mechanism. It has been shown by these workers that in accordance with the requirements of the hydroxylationdehydration mechanism a hydroxylated intermediate, ergosta-7,22-diene-3fl,S5a-diol (IIlb) , is smoothly converted into ergosterol under anaerobic conditions with a cell-free system obtained from homogenates of dry baker's yeast (Saccharomyces cerevswae Fleishmann). Our own results reported in this paper show that the main features of the introduction of the 5,6-double bond in ergosterol biosynthesis by whole cells of the yeast Saccharomyces cerevisiae LK2G12 are in remarkable harmony with those of the parallel reaction involved in the hepatic biosynthesis of cholesterol (Dewhurst & Akhtar, 1967) . Our observations as well as conclusions are therefore at variance with the work of Topham & Gaylor (1967) .
RESULTS AND DISCUSSION
Metabolism of 5,6-dihydroergosterol. By analogy with observations made in the biosynthesis of cholesterol (Dewhurst & Akhtar, 1967) , we considered that the 5,6-dihydroergosterol nucleus may be the immediate precursor of ring B of ergosterol. 3B and 3A) . The oxygen requirement for the introduction of the 5,6-double bond in ergosterol is the same as already established for the parallel reaction in cholesterol biosynthesis (Dewhurst & Akhtar, 1967; Dempsey, 1965) .
Stereochemistry of hydrogen elimination in the formation of the 5,6-double bond in ergosterol bio8ynthesis. We next attended to the determination of the stereochemistry of hydrogen elimination in the conversion of structure (IIb) into structure (VIIb). Ergosterol was hydrogenated with tritium gas in the presence of Raney nickel (Laubach & Brunings, 1952) . The knowledge that the catalytic hydrogenation involves a cis-addition of hydrogen to a double bond and the fact that in this particular case the hydrogen at the C-5 position is added from the a-side of the steroid molecule allows one to formulate the hydrogenated product as 5,6-dihydro[5a,6OC-3H2]ergosterol (Vb). The biosynthesis of ergosterol from 5,6-dihydro[5a,6a-3H2]-ergosterol (Vb) resulted (Table 2) in the complete removal of tritium from both the 5a-and the 6a-position. We therefore conclude that the introduction of the 5,6-double bond in ergosterol (VIIb) biosynthesis is accompanied by an overall ci-removal of the 5a-and 60c-hydrogen atoms. This result is in agreement with the stereochemistry of hydrogen elimination already established in the biosynthesis of cholesterol (Akhtar & Marsh, 1967) .
Metabolism of ergosta-7,22-diene-3fl,5a-diol (VIb).
To evaluate the possible involvement of a hydroxylation-dehydration mechanism in the biosynthesis of the 5,6-double bond of ergosterol, we synthesized ergosta-7,22-diene-3fl,5a-diol (VIb) (Clayton, Henbest & Jones, 1953) labelled with tritium at the 3ac-position. When the diol (VIb) was incubated Table 1 . Biological conversion of [3ox-3H]ergo8ta-7,22-dien-3fl-ol (IVb) and
In all the experiments 1 mg. of the substrate was used and incubations were carried out at 300. The specific radioactivities of compounds (IVb) and (VIb) were 2 x 106 and 7 x 105 counts/min./mg. respectively. In Expts. 1 and 2 the substrate was incubated in 41. of medium (Klein, Eaton & Murphy, 1954) with an inoculum (1-3mg.) of Saccharomyces cerevisiae LK2G12. Cells were harvested and total sterols were isolated and processed (Akhtar et al. 1966a (1954) into 3/,50c-dihydroxyergosta-7,22-dien-6-one 3-acetate and it was shown that this radioactivity was not located at C-5 or C-6, but somewhere else (side chain?) (see the Experimental section).
under anaerobic conditions with whole cells of Saccharomyces cerevisiae LK2G12 that had been grown either aerobically or anaerobically (Table 1; Expts. 4A, 5A and 6A), no conversion into ergosterol occurred. It is to be noted that Topham & Gaylor (1967) have provided spectroscopic evidence for the conversion of ergosta-7,22-diene-3fl,5a-diol (VIb) into ergosterol under anaerobic conditions with a partially purified enzyme system from dry baker's yeast (Saccharomyces cerevisiae Fleishmann).
The disagreement between the present work done in vivo and the previous work with a semi-purified system is not readily explicable. We were, however, able to demonstrate quite convincingly that, in parallel experiments carried out in the presence of oxygen, ergosta-7,22-diene-3,B,50c-diol (VIb) was readily converted into ergosterol ( Vol. 108 (Dewhurst & Akhtar, 1967) . The evidence presented in this paper therefore suggests that the mechanism of introduction of the 5,6-double bond in ergosterol biosynthesis closely resembles the mechanism proposed for the parallel reaction in cholesterol biosynthesis (Dewhurst & Akhtar, 1967) .
EXPERIMENTAL Infrared (i.r.) spectra were determined on a Unicam SP. 200 spectrometer. Nuclear-magnetic-resonance (n.m.r.) spectra were determined in deuterochloroform on a Varian model A 60 spectrometer. Optical rotations were measured in chloroform solutions with a Perkin-Elmer model 141 polarimeter. All compounds described below gave satisfactory i.r. spectra and n.m.r. spectra. For preparative thin-layer chromatography silica gel HF 254 (E. Merck A.-G., Darmstadt, Germany) was used. All radioactivity measurements were made on a Beckman liquid-scintillation system with 2-(4-tert. Preparation of 5o,8oc -epidioxyergosta -6,22 -dien -3, -ol 3-acetate. Ergosterol acetate (5g.) dissolved in ethanol (625ml.) together with eosin (30-40mg.) was irradiated under reflux by means of a 150w lamp placed beneath the flask, while oxygen was bubbled through the solution. This preparation was covered with aluminium foil. The reaction was stopped when the solution ceased to show the ergosterol absorption peak at 280m, (about 5hr.). The product was crystallized from ether-methanol (yield 2.5g.), m.p.
196-198°.
Preparation of ergo8ta-22-ene-3f,5c,8cc-triol 3-acetate.
5a,8ce-Epidioxyergosta-6,22-dien-3/3-ol 3-acetate (2g.) was dissolved in ethyl acetate (30ml.) and shaken in an atmosphere of hydrogen in the presence of Adams catalyst (100mg.) at 300. A dense white precipitate separated during the reaction. After 3hr. the uptake of hydrogen ceased when about 2mol.prop. of hydrogen was used. The precipitated material was removed and crystallized from chloroform-methanol (yield 1-2g.). Preparation of ergosta-7,22-diene-3,,5a-diol 3-acetate.
A solution of ergosta-22-ene-3fl,5a,8a-triol 3-acetate (1-2g.) in methanol (150ml.) was treated with a trace of HCI and the reaction mixture was left at room temperature for 30min. The resulting solid was removed by filtration and crystallized from chloroform-methanol (yield 640mg.), m.p. 2240, [z]21 +1-50. The above two experiments are based on the original work of Clayton et al. (1953) Preparation of ergosta-7,22-diene-3/3,5a-diol (IIlb) . A solution of ergosta-7,22-diene-3,B,5a-diol 3-acetate (640mg.) in sodium-dried ether (40ml.) was treated with LiAlH4 (200mg.) and the reaction mixture refluxed for 1 hr. The product was extracted with ether and crystallized from ether-methanol to give compound (IlIb) ( was dissolved in acetone (20ml.) and treated with Jones reagent (0. ml.).
The reaction mixture was stirred for 15min. and diluted with water, and the product was extracted with ether and after crystallization from ether-methanol was used in the next experiment without any further purification.
Preparation of . NaB3H4 (2-3mg.; specific radioactivity 1-2mc/mg.) was added to a solution of 5ac-hydroxyergosta-7,22-dien-3-one in methanol (20ml.) and the reaction mixture was kept at room temperature overnight. NaBH4 (8-10mg.) was then added to the same reaction mixture and the product was extracted with ether. Crystallization from ether-methanol gave a highly radioactive product, which was diluted with carrier to give compound (VIb) (specific radioactivity 234000 counts/min./mg.).
Preparation of ergosta-7,22-dien-3fl-ol (11b) (5,6-dihydroergosterol). Ergosterol (1g.) in dioxan (30ml.) was reduced in the presence ofRaney nickel (2-3 g.) at room temperature. The uptake of hydrogen ceased after 5hr., when approx. 1 mol.prop. of hydrogen gas was used. The catalyst was filtered over kieselguhr and the filtrate crystallized from ether-methanol to give compound (IIb) (yield 600mg.), m.p. 170°; Laubach & Brunings (1952) Preparation of ergosta-7,22-dien-3-one. A solution of ergosta-7,22-dien-3fl-ol (IIb) (150mg.) in acetone (25ml.) was treated with Jones reagent (0-12ml.). The reaction mixture was stirred for 10min. at 15°, diluted with water and extracted with ether. Crystallization from ethermethanol gave ergosta-7,22-dien-3-one (yield 60mg.).
Preparation of [3CX-3H]ergosta-7,22-dien-3fl-ol (I Vb) . To a solution of ergosta-7,22-dien-3-one (50mg.) in ether (5ml.) and methanol (25 ml.) was added NaB3H4 (1-2mg.) and the reaction mixture was left at room temperature for 1 hr. The reaction mixture was then treated with a further quantity of non-radioactive NaBH4 (10-15mg.) and left at room temperature for 2 hr. Dilution with water and extraction of the product with ether gave, after crystallization from ether-methanol, compound (IVb) (yield 20mg.; specific radioactivity 2072000 counts/min./mg.).
Preparation of [5,6-3H2]ergosta-7,22-dien-3fl-ol (Vb).
Ergosterol (100mg.) dissolved in dioxan (lOml.) was reduced in the presence of Raney nickel (1g.) with tritium gas, produced by dropping lithium metal into tritiated water (2ml. containing 50-lOOmc). The catalyst was removed by filtration and the filtrate crystallized from ether-methanol to give compound (Vb) (specific radioactivity 1358000 counts/min./mg.).
Determination of chemical purity. Radiochemical purity of all labelled compounds was determined by the procedure described by Akhtar, Hunt & Parvez (1967) .
Degradation of ergosterol biosynthesized from [5,6-3H2]-ergosta-7,22-dien-3f-ol (Vb) . Ergosterol acetate (320mg.; specific radioactivity 63 counts/min./mg.) biosynthesized from [5,6-3H2]ergosta-7,22-dien-3/3-ol (Vb) by the method of was suspended in acetic acid (7ml.) and treated with chromium trioxide (0-7ml.; 175mg. of CrO3 dissolved in 0-7 ml. of 80% acetic acid). The reaction mixture was stirred at room temperature for 1 hr. and then left at the same temperature overnight. Addition of methanol (a few drops) and dilution with water gave a solid that was crystallized from ethyl acetate to give 3/3,5cz-dihydroxyergosta-7,22-dien-6-one 3-acetate (specific radioactivity 57 counts/min./mg.). The complete retention of radioactivity in this conversion proves that the label is not located at C-5 or C-6, but somewhere else in the molecule (side chain?).
